As part of its ongoing campaign to raise awareness for breast cancer prevention, Medline Industries, Inc. announces the launch of its new "Pink Pearl" powder-free nitrile exam glove. To aid the prevention and early detection effort, Medline will donate $1 to the National Breast Cancer Foundation for each case sold of the new pink glove.
The Pink Pearl combines the properties of nitrile for superior barrier protection with an organic aloe vera lining for comfort. The glove also features a bright pink sheen to create a glamorous appearance and a visual reminder of breast cancer awareness. The glove is the newest member of the "Generation Pink" exam glove family, in which all the gloves are colored pink to convey breast cancer awareness. The Generation Pink line includes a standard nitrile exam glove and the original vinyl glove featuring patented third generation technology.
"The new Pink Pearl, like all of our Generation Pink gloves, is a tangible symbol of our ongoing commitment to breast cancer awareness, early detection and prevention," says Brian Palmer, president of Medline's glove division. "Gloves are the first point of contact between the healthcare worker and the patient, and because they are pink, we hope they will get people talking about breast cancer."
Medline provides a complete line of latex and latex-free products featuring patented aloe and 3G technologies. This 3G technology features an advanced polymer formulation that offers outstanding sensitivity with a unique softness and flexibility.
The introduction of the new Pink Pearl is a continuation of Medline's support of breast cancer awareness and early detection. Every pink gloves sale supports Medline's partnership with the National Breast Cancer Foundation to help fund mammograms for women who cannot afford them. Medline also builds breast cancer awareness at forums for nurses and other healthcare workers, and through social media and events such as the Pink Glove Dance video. The original video has been seen more than 11 million times since it was introduced in 2009. The sequel to the Pink Glove Dance video will premiere Sept. 17, 2010 at www.pinkglovedance.com
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
COVID-19 Realities: Beyond a Respiratory Virus, Addressing Optimism in Pandemic Management
February 28th 2024A recent commentary by Dr. Amesh Adalja in MedPage Today challenges the perception of COVID-19 as solely a respiratory virus, highlighting its broader impact on the body. This analysis questions the notion that COVID-19 should be managed like common respiratory infections, urging a closer look at vaccine effectiveness, the rise of long COVID, and the need for enhanced measures to curb the virus's spread. Let's explore the complexities of COVID-19 management and the pressing realities faced by the US and the world.